The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of necitumumab continuation therapy: Subgroup analysis of phase 3 SQUIRE study.
 
Tudor E. Ciuleanu
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Lilly; Merck; Roche Pharma AG
Research Funding - ACT Biotech; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Genentech; Lilly; MSD; Pfizer; Roche Pharma AG
 
Mark A. Socinski
No Relationships to Disclose
 
Coleman K. Obasaju
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Alexander Luft
No Relationships to Disclose
 
Aleksandra Szczesna
No Relationships to Disclose
 
Wojciech Szafranski
No Relationships to Disclose
 
Rodryg Ramlau
Honoraria - Lilly
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; MSD
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly
 
Beatrix Bálint
No Relationships to Disclose
 
Andrzej Kazarnowicz
No Relationships to Disclose
 
Olivier Molinier
Consulting or Advisory Role - Roche Pharma AG
 
Henrik Depenbrock
Employment - Dentschland; Lilly; Simon-Kucher and Partners
Stock and Other Ownership Interests - Lilly
 
Shivani Nanda
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Luis Paz-Ares
Honoraria - Lilly
 
Nick Thatcher
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly